Patent ID: 11925607
Assignee: CELON PHARMA S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of ftreating depression in a subject comprising administration to the lungs of the subject via pulmonary route of an inhalable pharmaceutical composition comprising ketamine or its isomer or its pharmaceutically acceptable salt, wherein said treating is performed in a dosage regimen that comprises a 10 days to a 30 days cycle of multiple administrations by inhalation, wherein each administration of the multiple administrations is performed on a single day with an interval of 2 to 4 days between each administration, wherein each administration of the multiple administrations consists of a sequence of multiple single dose inhalations, and wherein each single dose inhalation in said sequence is separated by a break period lasting about 15 minutes.